In addition, given that the development of resistance to platinum agents is linked to genes involved in DNA damage response pathways (Richardson and Kaye, 2005), one of the known functions of EDD, we also determined if EDD expression was associated with sensitivity to cisplatin in serous ovarian cancer. This evidence concerns the gene UBR5 and ovarian serous adenocarcinoma.